Palonosetron Hydrochloride News
Palonosetron Hydrochloride currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Palonosetron Hydrochloride with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Aloxi is indicated in adults for: the prevention of acute nausea and vomiting associated with highly emetogenic cancer chemotherapy, the prevention of nausea and vomiting associated with moderately...
- Evidence level: L5
- Predicted indications (20):
- migraine disorder (99.7%)
- migraine with brainstem aura (99.7%)
- migraine with or without aura, susceptibility to (99.4%)
- atrophoderma vermiculata (99.1%)
- ulerythema ophryogenesis (99.1%)
- headache disorder (97.9%)
- trigeminal autonomic cephalalgia (97.6%)
- open-angle glaucoma (96.5%)
- sciatic neuropathy (96.4%)
- primary hereditary glaucoma (96.4%)
- dysthymic disorder (96.1%)
- nephrogenic syndrome of inappropriate antidiuresis (95.8%)
- insomnia (disease) (95.3%)
- congenital hypotrichosis milia (95.2%)
- multiple system atrophy (95.1%)
- diffuse alopecia areata (95.1%)
- hypotrichosis simplex of the scalp (94.9%)
- duodenum cancer (94.7%)
- phaeochromocytoma (94.7%)
- irritable bowel syndrome (94.6%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.